Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3676915018 | Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3676916017 | Atovaquone 62.5 mg and proguanil 25 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Product containing proguanil hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Product containing atovaquone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Atovaquone+proguanil hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has active ingredient | Atovaquone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil hydrochloride (substance) | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has active ingredient | Biguanide (substance) | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Proguanil hydrochloride 100 mg oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Product containing atovaquone and proguanil (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Proguanil-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil | false | Inferred relationship | Some | 1 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Proguanil | false | Inferred relationship | Some | 1 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 1 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has active ingredient | Atovaquone (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Atovaquone (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 62.5 | false | Inferred relationship | Some | 2 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Atovaquone- and proguanil-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has precise active ingredient | Proguanil | false | Inferred relationship | Some | 1 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Has precise active ingredient | Atovaquone (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet | Is a | Atovaquone and proguanil only product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR